Cooley advised the underwriters on Aquestive Therapeutics’ $73.9 million initial public offering of 4,925,727 shares of common stock, which includes the partial exercise of the underwriters’…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now